Results 151 to 160 of about 22,987 (189)
Some of the next articles are maybe not open access.
Irregular Supraventricular Tachycardia
JAMA Internal Medicine, 2013An86-year-oldwomanwithaknownhistoryofcoronaryarterydisease and a prior percutaneous coronary intervention presented to the emergency department with several episodes of selfresolving chest discomfort occurring at rest. She denied any shortness of breath, palpitations, and diaphoresis. Her home medications included a β-blocker.
Edgar, Argulian +3 more
openaire +2 more sources
Spectrum of supraventricular tachycardias
The American Journal of Cardiology, 1988The term "supraventricular tachycardia" includes a wide variety of arrhythmias with very different clinical and prognostic significance. Each supraventricular tachycardia has unique characteristics and each patient, even when similar arrhythmias are present, remains a person with specific manifestations. In 1988, physicians should not be satisfied with
P, Brugada, J L, Smeets, H J, Wellens
openaire +2 more sources
Intrauterine Supraventricular Tachycardia
Acta Obstetricia et Gynecologica Scandinavica, 1978Abstract. Four cases of intra‐uterine ectopic supraventricular tachycardia are described. In three there were none or only minor symptoms immediately after delivery and subsequently. The fourth baby having a congenital W–P–W‐syndrome was born with severe hydrops fetalis and was asphyxiated.
N H, Valerius, J R, Jacobsen
openaire +2 more sources
Paroxysmal supraventricular tachycardias
The Journal of Emergency Medicine, 1996Paroxysmal supraventricular tachycardia (PSVT) is a distinct clinical syndrome. Most patients present with the abrupt onset of palpitations, dizziness, dyspnea, or chest pain. The electrocardiogram (ECG) demonstrates a fast heart rate (150-250 beats per min), a regular rhythm, and most often, a narrow QRS complex.
S R, Lowenstein +2 more
openaire +2 more sources
Gemcitabine-Induced Supraventricular Tachycardia
Tumori Journal, 2009The superior toxicity profile is one of the major reasons for the widespread use of gemcitabine in cancer treatment. Bone marrow suppression is the most common side effect, while non-hematological events are relatively infrequent. Cardiac toxicity is a rare complication and cardiac arrhythmia is even rarer.
Oshrat E Tayer-Shifman +2 more
openaire +2 more sources
Phenothiazine-associated supraventricular tachycardia
Australian and New Zealand Journal of Psychiatry, 1994Psychotropic medications, mainly phenothiazines, are known to be associated with cardiac insult. The case report presented here describes nearly fatal arrhythmia (sustained supraventricular tachycardia) consequent to phenothiazine treatment. The authors aim to alert psychiatrists to the possible adverse, and even fatal, effects of phenothiazines.
R, Durst, P, Rosca-Rebaudengo, D, Admon
openaire +2 more sources
Postgraduate Medicine, 1991
The various forms of supraventricular tachycardia can be differentiated by careful review of a patient's electrocardiogram. If reentrant tachycardia involves the atrioventricular node, intravenous adenosine (Adenocard) provides a rapid means of converting the tachycardia to sinus rhythm.
openaire +2 more sources
The various forms of supraventricular tachycardia can be differentiated by careful review of a patient's electrocardiogram. If reentrant tachycardia involves the atrioventricular node, intravenous adenosine (Adenocard) provides a rapid means of converting the tachycardia to sinus rhythm.
openaire +2 more sources
Stimuli to Supraventricular Tachycardia
Annals of Internal Medicine, 1978Excerpt To the editor: The review "Supraventricular Tachycardia: Mechanisms and Management" by Josephson and Kastor (Ann Intern Med87:346-358, 1977) emphasizes that sustained re-entry is the mechan...
openaire +2 more sources
Management of supraventricular tachycardias
British Journal of Hospital Medicine, 2014Sukhjinder S, Nijjer +3 more
openaire +2 more sources